Kraig Biocraft Laboratories Establishes Homozygosity and Confirms BAM 1 Hybrid Optimized Ahead of Spring Production Trials
Establishing homozygosity for the targeted gene in both parental strains means that the Company's new BAM 1 hybrid production system is optimized for recombinant spider silk production.
- Establishing homozygosity for the targeted gene in both parental strains means that the Company's new BAM 1 hybrid production system is optimized for recombinant spider silk production.
- The BAM 1 hybrid represents the Company's latest innovation in the commercialization of recombinant spider silk technology.
- Achieving homozygosity for both BAM 1 parental strains is another significant milestone in the commercialization of recombinant spider silk.
- "Our team set an aggressive deadline for achieving homozygosity in the BAM 1 hybrid ahead of our spring production trials," said CEO and Founder, Kim Thompson.